[1]
Gritenaitė, D.M. et al. 2025. Beyond Diabetes Mellitus and weight loss: the potential effect of GLP-1 agonist drugs in the treatment of Parkinson’s Disease. Junior Researchers. 3, 2 (May 2025), 159–175. DOI:https://doi.org/10.52340/jr.2025.03.02.26.